Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children

PHASE3CompletedINTERVENTIONAL
Enrollment

466

Participants

Timeline

Start Date

August 10, 2009

Primary Completion Date

September 16, 2010

Study Completion Date

October 27, 2010

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Pneumococcal vaccine GSK1024850A

1 or 2 intramuscular injections

Trial Locations (10)

70800

GSK Investigational Site, Ostrava

628 00

GSK Investigational Site, Brno

500 01

GSK Investigational Site, Hradec Králové

377 01

GSK Investigational Site, Jindřichův Hradec

547 01

GSK Investigational Site, Náchod

532 03

GSK Investigational Site, Pardubice

150 00

GSK Investigational Site, Prague

160 00

GSK Investigational Site, Prague

190 00

GSK Investigational Site, Prague

669 00

GSK Investigational Site, Znojmo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY